Dr. Farhan J. Khawaja, MD

Dr. Khawaja practices at Arnold Palmer Hospital for Children in Orlando, Florida.

Dr. Khawaja's NPI, 1669489209, was assigned on August 2, 2006. Dr. Khawaja graduated from Albany Medical College in 2005. Dr. Khawaja holds Florida license ME121488.

Dr. Khawaja's primary practice is Arnold Palmer Hospital for Children, at 92 W Miller St, Orlando, FL 32806 in Orange County. The practice phone is (407) 650-5028.

Dr. Khawaja's primary practice is Arnold Palmer Hospital for Children in Orlando, Florida. Dr. Khawaja is also affiliated with AdventHealth Orlando. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Khawaja to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khawaja practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Khawaja's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Khawaja is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Khawaja's licenses on file in 4 states: Florida, Oklahoma, New York and Minnesota.

Dmand AI lists angioplasty, cardiac catheterization and leg revascularization among the conditions Dr. Khawaja treats.

CMS data shows 2,896 Medicare services from Dr. Khawaja across 29 procedure codes in 2024, for 1,121 Medicare patients. Medicare paid $178,530 for them.

CMS counts 1,121 Medicare patients who saw Dr. Khawaja in 2024. The largest group is 65 to 74, with 451 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khawaja's median patient age at 72, with 47% women.

In 2024, Dr. Khawaja wrote 3,518 Medicare Part D claims for 506 patients. 84% of them were for generic drugs. CMS names the drug for 3,267 of them, across 37 drugs with 11 or more claims each, at $517,233 in total drug cost. In 2023, CMS named 2,329 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Khawaja for performance year 2024, reported as part of a group. Dr. Khawaja accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khawaja as offering telehealth. CMS counts 53 procedures of coronary angioplasty and stenting by Dr. Khawaja, more than 85% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Khawaja, published from 2011 to 2022. 2013 was the busiest year, with 2. The most frequent topics are Angioplasty, Balloon, Coronary, Critical Illness and Endovascular Procedures. Dr. Khawaja's most frequent co-authors are George L. Adams, MD, Bernard J. Gersh, MBCHB and Philip Paul Goodney, MD.

Dmand AI links Dr. Khawaja to 1 clinical trial. Conditions studied include Chronic Limb-Threatening Ischemia and Peripheral Arterial Disease.

CMS Open Payments shows 356 general payments to Dr. Khawaja from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 44% of the total. Medtronic, Inc. paid the most, $72,511.

Dmand AI lists 2 awards for Dr. Khawaja.

Dr. Khawaja graduated from Albany Medical College in 2005. Dr. Khawaja is a member of AOA and ACC.

Dr. Khawaja is in network with 18 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.